BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 29, 2011
View Archived Issues
Novel antifungal agents synthesized by Polichem
Read More
New dual IGF-I receptor/IR inhibitor is active in models of multiple myeloma
Read More
Ironwood Pharmaceuticals licenses Depomed's gastric retentive drug delivery technology
Read More
Scientists identify potential serum biomarker of neurofibromatosis type 1
Read More
Biogen Idec and Neurimmune disclose in vivo data on antibodies targeting Abeta peptides
Read More
Study investigates dyslipidemia-promoting mechanisms in obesity
Read More
Sanofi claims new antagonists of TNF receptor superfamily member 16
Read More
CNIO patents novel protein kinase pim inhibitors
Read More
ArQule prepares novel protein kinase inhibitors
Read More
Immunotec and Nova Southeastern University to test autism treatment
Read More
Adaptimmune's T-cell therapy enters pilot trial in synovial sarcoma
Read More
BioMarin reports preliminary results from phase I/II extension study of GALNS
Read More
Reply submitted to FDA's complete response letter on Bydureon NDA
Read More
Ribovax out-licenses SEBVI antibody technology
Read More
Enrollment begins in randomized phase II trial of NGR-hTNF in ovarian cancer
Read More
Data presented on long-term efficacy of raltegravir in HIV infection
Read More
Micell Technologies completes accrual in DESSOLVE II study
Read More
Enrollment complete in pivotal phase III SETTLE trial of safinamide mesilate
Read More
Yaupon Therapeutics files NDA for mechlorethamine gel
Read More
RegeneRx to commence phase II trial of RGN-259
Read More
FDA issues refuse to file letter in response to Eisai's NDA for perampanel
Read More
Lexicon Pharmaceuticals completes phase I trial of LX-1033
Read More
Otsuka vasopressin V2 receptor antagonist approved for hyponatremia in Canada
Read More
FDA awards orphan drug status to Diffusion Pharmaceuticals' TSC
Read More